Enclosed is the press release.

August 5, 2026 BSE Limited National Stock Exchange of India Limited The Listing Department The Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, G Block, 25th Floor, Dalal Street Bandra Kurla Complex Fort, Mumbai 400 001 Bandra (East), Mumbai 400051 Maharashtra, India Maharashtra, India BSE Scrip Code: 544309 NSE Symbol: IKS Dear Sir/Ma’am, Sub: Press Release – Financial Results (Standalone and Consolidated) for the quarter ended June 30, 2026. Press Release in respect of Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026, is enclosed herewith. Request you to take it on record and disseminate the same on your website. Thanking you. Yours sincerely, For Inventurus Knowledge Solutions Limited Sameer Chavan Company Secretary and Compliance Officer Membership No. F7211 Encl: As above Inventurus Knowledge Solutions Limited Registered Address: 801, Building No. 5, 8th Floor, Mindspace Business Park (SEZ), Thane-Belapur Road, Airoli, Navi Mumbai – 400708, Thane, Maharashtra, India Ph.: +91 22 3071 1100 | W: www.ikshealth.com | CIN: L72200MH2006PLC337651 PRESS RELEASE IKS Health Delivers Strong Q1 FY27 Results with 21% Year-over-Year Revenue Growth and 28% Year-over-Year PAT Increase ● Q1 Revenue growth 21% YoY in INR, 12% YoY in USD ● Q1 EBITDA 24% YoY ● Q1 PAT up 28% YoY Mumbai, India | August 05, 2026: Inventurus Knowledge Solutions Limited (NSE: IKS), a global healthcare technology company, today announced its financial results for the quarter ended June 30, 2026, reporting strong revenue and profit growth in Q1 FY 2027. IKS Health partners with health systems, physician groups, specialty practices, and rural and community hospitals to improve operational efficiency, financial sustainability, and care delivery through technology-enabled solutions and deep healthcare expertise. The IKS Health platform integrates agentic AI workflows with human expertise to create smarter, more accurate operations, better outcomes, and financially sustainable growth across the care journey. "This quarter's results showcase the resilience of our business model, powered by strong client trust, operational efficiency, and a scalable care enablement platform. This continued momentum builds on a decade of profitable growth, marked by an impressive 46% PAT CAGR," said Sachin K. Gupta, Founder & Global CEO, IKS Health. “The acquisition of TruBridge marks an important milestone in our growth journey, expanding our capabilities and strengthening our ability to serve a broader range of healthcare organizations, including rural and community health systems. By bringing together complementary expertise, technology, and healthcare capabilities, we are well-positioned to create greater value for our clients and drive sustainable growth over the long term." Nithya Balasubramanian, Group CFO, IKS Health said, “We closed Q1 FY27 with robust financial results, delivering 21% YoY revenue growth and a 28% YoY growth in PAT. These outcomes are a direct result of our unwavering focus on cost discipline, platform scalability, and capital efficiency. As we look to the rest of the fiscal year, our priority remains clear: protecting our margins while investing prudently in the strategic capabilities that secure long-term value.” Key Financial Highlights: Q1FY27 ended on June 30, 2026 ● Revenue at INR 8,936 Mn; 20.7% YoY ● EBITDA at INR 2,949 Mn at 33% of revenue; 24% YoY ● PAT at INR 1,937 Mn at 21.7% of revenue; 27.8% YoY ● Adjusted PAT at INR 2,153 Mn at 24.1% of revenue; 28.0% YoY Recognition & Awards IKS Health received the below notable recognitions: 1. U.S. patent granted for our proprietary Engagement Learning Engine - AI-driven “Awareness-Ability-Willingness” (AAW) behavioral modeling powers IKS Health’s patient access solutions including MyCareHub which enhances patient engagement and optimizes patient scheduling. 2. 2026 Dallas-Fort Worth Titan 100 - Titan CEO - Sachin K. Gupta, Founder & Global CEO 3. Best CFO & Finance Strategy Excellence Awards 2026 ● Excellence in Investor Relations (Organisational category) ● Best CFO in Healthcare – Nithya Balasubramanian, Whole-time Director & Group CFO (Individual category) 4. FE HR Awards 2026 ● Excellence in Onboarding and Role Enablement 5. American Medical Group Association (AMGA) - Distinguished Corporate Partner Award 2026 Safe Harbour Certain statements in this release concerning our future growth prospects may be seen as forward-looking statements, which involve a number of risks and uncertainties that could cause the actuals to differ materially from such statements. It is not possible to undertake to update any such statement that may have been made from time to time. —--------------------------------------------------------------------------------------------------------------------- About IKS Health IKS Health reduces the administrative, clinical, and operational burdens that slow healthcare down, giving clinicians and care teams the freedom to focus on delivering exceptional care. Through its Care Enablement platform, IKS Health integrates AI, agentic workflows, and human expertise to create smarter operations, better outcomes, and financially sustainable growth across the care journey. Founded in 2006 and recognized by Black Book as the top provider of AI-driven RCM services, by KLAS for performance and client satisfaction, and by Google Cloud with the 2025 DORA Award for “Augmenting Human Expertise with AI,” IKS Health partners with the largest health systems, physician groups, and specialty practices across the United States. Learn more at ikshealth.com. Inventurus Knowledge Solutions Limited was listed on National Stock Exchange of India Limited (NSE) and BSE Limited (Bombay Stock Exchange) on December 19, 2024. {Scrip codes: NSE - IKS and BSE - 544309} MEDIA CONTACT - IKS HEALTH INVESTOR RELATIONS CONTACT - IKS HEALTH Sameer Arora Saransh Mundra Senior Vice President Head - Investor Relations press@ikshealth.com investor_relations@ikshealth.com -xx-xx-xx-